Computational neural network analysis of the affinity of lobeline and tetrabenazine analogs for the vesicular monoamine transporter-2

被引:23
|
作者
Zheng, Fang [1 ]
Zheng, Guangrong [1 ]
Deaciuc, A. Gabriela [1 ]
Zhan, Chang-Guo [1 ]
Dwoskin, Linda P. [1 ]
Crooks, Peter A. [1 ]
机构
[1] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA
关键词
lobeline analog; QSAR; partial least squares; artificial neural network; VMAT2;
D O I
10.1016/j.bmc.2007.02.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Back-propagation artificial neural networks (ANNs) were trained on a dataset of 104 VMAT2 ligands with experimentally measured log(l/K-i) values. A set of related descriptors, including topological, geometrical, GETAWAY, aromaticity, and WHIM descriptors, was selected to build nonlinear quantitative structure-activity relationships. A partial least squares (PLS) regression model was also developed for comparison. The nonlinearity of the relationship between molecular descriptors and VMAT2 ligand activity was demonstrated. The obtained neural network model outperformed the PLS model in both the fitting and predictive ability. ANN analysis indicated that the computed activities were in excellent agreement with the experimentally observed values (r(2) = 0.91, rmsd = 0.225; predictive q(2) = 0.82, loormsd = 0.316). The generated models were further tested by use of an external prediction set of 15 molecules. The nonlinear ANN model has r(2) = 0.93 and root-mean-square errors of 0.282 compared with the experimentally measured activity of the test set. The stability test of the model with regard to data division was found to be positive, indicating that the generated model is predictive. The modeling study also reflected the important role of atomic distribution in the molecules, size, and steric structure of the molecules when they interact with the target, VMAT2. The developed models are expected to be useful in the rational design of new chemical entities as ligands of VMAT2 and for directing synthesis of new molecules in the future. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2975 / 2992
页数:18
相关论文
共 23 条
  • [1] Ephedrine Decreases Vesicular Monoamine Transporter-2 Function
    Ellis, Jonathan D.
    German, Christopher L.
    Birdsall, Elisabeth
    Hanson, Jarom E.
    Crosby, Marcus A.
    Rowley, Shane D.
    Sawada, Nicole A.
    West, Jeremiah N.
    Hanson, Glen R.
    Fleckenstein, Annette E.
    SYNAPSE, 2011, 65 (05) : 449 - 451
  • [2] Methylphenidate redistributes vesicular monoamine transporter-2: Role of dopamine receptors
    Sandoval, V
    Riddle, EL
    Hanson, GR
    Fleckenstein, AE
    JOURNAL OF NEUROSCIENCE, 2002, 22 (19) : 8705 - 8710
  • [3] The molecular chaperone Hsc70 interacts with the vesicular monoamine transporter-2
    Requena, Daniela F.
    Parra, Leonardo A.
    Baust, Tracy B.
    Quiroz, Marisol
    Leak, Rehana K.
    Garcia-Olivares, Jennie
    Torres, Gonzalo E.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 (02) : 581 - 594
  • [4] 9-Cyclopropylmethoxy-dihydrotetrabenazine and its stereoisomers as vesicular monoamine transporter-2 inhibitors
    Wang, Wenyan
    Lin, Shilan
    Du, Guangying
    Bai, Xinfa
    Lu, Jing
    Ye, Liang
    Wang, Hongbo
    Zhang, Rui
    Tian, Jingwei
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (13) : 991 - 1003
  • [5] Synthesis and evaluation of a series of tropane analogues as novel vesicular monoamine transporter-2 ligands
    Zheng, GR
    Dwoskin, LP
    Deaciuc, AG
    Crooks, PA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (20) : 4463 - 4466
  • [6] Synthesis and in vitro evaluation of water-soluble 1,4-diphenethylpiperazine analogs as novel inhibitors of the vesicular monoamine transporter-2
    Nickell, Justin R.
    Culver, John P.
    Janganati, Venumadhav
    Zheng, Guangrong
    Dwoskin, Linda P.
    Crooks, Peter A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (18) : 4441 - 4445
  • [7] Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: Neurotoxic and therapeutic implications
    Fleckenstein, Annette E.
    Volz, Trent J.
    Hanson, Glen R.
    NEUROPHARMACOLOGY, 2009, 56 : 133 - 138
  • [8] GZ-793A, a lobelane analog, interacts with the vesicular monoamine transporter-2 to inhibit the effect of methamphetamine
    Horton, David B.
    Nickell, Justin R.
    Zheng, Guangrong
    Crooks, Peter A.
    Dwoskin, Linda P.
    JOURNAL OF NEUROCHEMISTRY, 2013, 127 (02) : 177 - 186
  • [9] GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine
    Lee, Na-Ra
    Zheng, Guangrong
    Leggas, Markos
    Janganati, Venumadhav
    Nickell, Justin R.
    Crooks, Peter A.
    Bardo, Michael T.
    Dwoskin, Linda P.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 371 (02) : 526 - 543
  • [10] Synthesis and preliminary evaluation of 131I-9-iodovinyl-tetrabenazine targeting vesicular monoamine transporter 2
    Cao, Lihua
    Xie, Minhao
    Zhao, Chao
    Tang, Jie
    Liu, Chunyi
    Xu, Yingjiao
    Li, Xiaomin
    Liu, Yi
    Chen, Zhengping
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2018, 317 (01) : 315 - 323